OneChain Immunotherapeutics, a spin-off from the Josep Carreras Leukemia Research Institute and ICREA, specializes in developing innovative CAR-T therapies for hematological cancers. Under the leadership of Dr. Pablo Menéndez, the company focuses on creating targeted treatments that specifically attack unique antigens in these diseases.
National Ranking2012th
in Spain Regional Ranking23100th
in Western Europe Global Ranking93199th
worldwide Rankings by